Marc Stapley Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 months, 4 weeks ago
Marc Stapley has an estimated net worth of at least $13.2 million*, as of Oct. 29, 2025. They own 318,603 shares of VCYT stock. They have sold 123,622 shares of VCYT stock since 2021, for an estimated $1.3 million.
Marc Stapley $VCYT SEC Form 4 Insider Trading
Marc Stapley has filed a total of 9 insider trades in $VCYT since 2021. Their most recent trade was a sale of 4,448 shares, made on Dec 04, 2025. Their largest trade was a purchase of 60,000 shares, made on Jun 10, 2022. We estimate that they now own 318,603 shares of $VCYT, worth an estimated $11.9 million.
Insider Trading at $VCYT
There have been a total of 142 insider trades reported at $VCYT since 2021, with 62,000 shares purchased and 1.1 million shares sold. The most active insider traders in $VCYT stock have been Giulia C Kennedy, John Leite, and Marc Stapley. The most recent trade was a sale of 10,639 shares reported by Annie McGuire (SVP, General Counsel), made on Dec 16, 2025.
History of Insider Stock Trades by Marc Stapley
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
GKOS
|
Sale | 3,812 | Jan 22, 2026 | Jan. 26, 2026, 10:21 p.m. |
|
GKOS
|
Sale | 1,300 | Jan 22, 2026 | Jan. 26, 2026, 10:21 p.m. |
|
GKOS
|
Sale | 4,325 | Jan 22, 2026 | Jan. 26, 2026, 10:21 p.m. |
|
GKOS
|
Sale | 1,671 | Jan 22, 2026 | Jan. 26, 2026, 10:21 p.m. |
|
GKOS
|
Sale | 3,892 | Jan 22, 2026 | Jan. 26, 2026, 10:21 p.m. |
VCYT
|
Sale | 4,448 | Dec 04, 2025 | Dec. 4, 2025, 8:44 p.m. |
|
VCYT
|
Sale | 3,220 | Dec 04, 2025 | Dec. 4, 2025, 8:44 p.m. |
|
VCYT
|
Sale | 7,667 | Sep 04, 2025 | Sept. 8, 2025, 4:33 p.m. |
|
VCYT
|
Sale | 1,094 | Mar 04, 2025 | March 6, 2025, 5:41 p.m. |
|
VCYT
|
Sale | 23,414 | Mar 04, 2025 | March 6, 2025, 5:41 p.m. |
|
VCYT
|
Sale | 28,189 | Mar 04, 2025 | March 6, 2025, 5:41 p.m. |
|
VCYT
|
Sale | 400 | Dec 13, 2024 | Dec. 17, 2024, 5:31 p.m. |
|
VCYT
|
Sale | 5,190 | Dec 13, 2024 | Dec. 17, 2024, 5:31 p.m. |
|
GKOS
|
Sale | 581 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 600 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 1,110 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 3,959 | Aug 15, 2024 | Aug. 19, 2024, 5:15 p.m. |
|
GKOS
|
Sale | 2,200 | May 15, 2024 | May 16, 2024, 7:45 p.m. |
|
GKOS
|
Sale | 2,000 | May 15, 2024 | May 16, 2024, 7:45 p.m. |
|
GKOS
|
Sale | 2,050 | May 15, 2024 | May 16, 2024, 7:45 p.m. |
|
GKOS
|
Sale | 2,437 | Feb 29, 2024 | March 4, 2024, 9:09 p.m. |
|
GKOS
|
Sale | 2,313 | Feb 29, 2024 | March 4, 2024, 9:09 p.m. |
|
GKOS
|
Sale | 1,500 | Feb 29, 2024 | March 4, 2024, 9:09 p.m. |
|
GKOS
|
Sale | 9,206 | Dec 14, 2023 | Dec. 18, 2023, 9:40 p.m. |
|
GKOS
|
Sale | 7,044 | Dec 14, 2023 | Dec. 18, 2023, 9:40 p.m. |
|
VCYT
|
Purchase | 60,000 | Jun 10, 2022 | June 13, 2022, 8:19 a.m. |
$VCYT Executives and Stock Owners with Insider Trades
-
Giulia C Kennedy, Chief Scientific & Med Officer
-
John Leite, Chief Commercial Officer-CLIA
-
Marc Stapley, Chief Executive Officer
-
Annie Mcguire, SVP, General Counsel
-
Bonnie H Anderson, Executive Chairwoman
-
Rebecca Chambers, Chief Financial Officer
-
Jonathan Wygant, VP, Chief Accounting Officer
-
Phillip G. Febbo, Chief Scientific & Med Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.